Blizzard Doesn't Stop PDUFA Talks
This article was originally published in The Pink Sheet Daily
Despite government closure, FDA and industry meet in aftermath of DC-area snowstorm to keep talks on schedule.
You may also be interested in...
Talks between US FDA and industry to extend the generic drug and prescription drug user fee programs may last into 2021.
Both ideas also will require more FDA expertise, agency tells industry.
Additional power would allow the agency to punish 'simple' REMS violations and improve administration of risk management programs, according to a new report looking at FDA's oversight of opioids.